Amicus Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
14.82
|
|
Average Rating
|
4.15
|
|
# Strong Buys
|
7
|
|
# Buys
|
1
|
|
# Holds
|
5
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.19
|
-0.12
|
0.07
|
36.84%
|
|
2022-06-30
|
-0.22
|
-0.21
|
0.01
|
4.55%
|
|
2022-03-31
|
-0.25
|
-0.30
|
-0.05
|
-20.00%
|
|
2021-12-31
|
-0.16
|
-0.29
|
-0.13
|
-81.25%
|
|
2021-09-30
|
-0.17
|
-0.19
|
-0.02
|
-11.76%
|
|
2021-06-30
|
-0.21
|
-0.19
|
0.02
|
9.52%
|
|
2021-03-31
|
-0.23
|
-0.25
|
-0.02
|
-8.70%
|
|
2020-12-31
|
-0.22
|
-0.27
|
-0.05
|
-22.73%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.63
|
|
2021-12-31
|
-0.92
|
|
2020-12-31
|
-1.07
|
|
2019-12-31
|
-1.51
|
|
2018-12-31
|
-1.86
|
|
2017-12-31
|
-1.83
|
|
2016-12-31
|
-1.50
|
|
2015-12-31
|
-1.20
|
|
2014-12-31
|
-0.93
|
|
2013-12-31
|
-1.13
|
|
2012-12-31
|
-1.09
|
|
2011-12-31
|
-1.29
|
|
2010-12-31
|
-1.99
|
|
2009-12-31
|
-0.29
|
|
2008-12-31
|
-1.74
|
|
2007-12-31
|
-2.36
|